Federal Grant System Under Siege: The OMB’s Proposed Overhaul and the Battle for Scientific Integrity on November 21, 2026 Posted by
Protecting the Next Generation: Istanbul Summit Confronts the Escalating Youth Nicotine Crisis on November 21, 2026 Posted by
Biopharma Industry Weekly Briefing: Strategic Shifts, Clinical Setbacks, and AI Partnerships on November 21, 2026 Posted by
Beyond the Wake: Uncovering the Hidden Cardiovascular Risks of Narcolepsy and Idiopathic Hypersomnia on November 21, 2026 Posted by
Clash of Titans: Thailand and Vietnam Set for High-Stakes ASEAN Cup 2026 Final Showdown on November 21, 2026 Posted by
Federal Grant System Under Siege: The OMB’s Proposed Overhaul and the Battle for Scientific Integrity on November 21, 2026 Posted by
Protecting the Next Generation: Istanbul Summit Confronts the Escalating Youth Nicotine Crisis on November 21, 2026 Posted by
Biopharma Industry Weekly Briefing: Strategic Shifts, Clinical Setbacks, and AI Partnerships on November 21, 2026 Posted by
Posted in Sleep Health A Paradigm Shift in Sleep Medicine: FDA Approves Orzeyful to Address the Root Cause of Narcolepsy Type 1 on August 17, 2026
Posted in Medical Innovations A New Era in Immunization: FDA Approves Moderna’s mRNA-Based Flu Vaccine on August 8, 2026
Posted in Caregiver Support A New Era in Influenza Protection: FDA Approves Moderna’s mRNA-Based Flu Vaccine on August 8, 2026
Posted in Medical Innovations A New Era in Immunization: FDA Approves First mRNA Influenza Vaccine for Adults 50 and Older on August 7, 2026
Posted in Sleep Health A Paradigm Shift in Sleep Medicine: FDA Approves Orzeyful to Target the Root Cause of Narcolepsy Type 1 on August 7, 2026
Posted in Digital Health Tools A New Era in Immunology: FDA Approves Moderna’s mRNA-Based Influenza Vaccine on August 7, 2026
Posted in Medical Innovations A Paradigm Shift in Sleep Medicine: FDA Approves Oveporexton for Narcolepsy Type 1 on August 7, 2026
Posted in Respiratory Health A New Dawn for Narcolepsy Type 1: FDA Approves Orzeyful, the First Orexin-Targeting Therapy on August 6, 2026
Posted in Respiratory Health A Breakthrough in Trauma Care: FDA Approves First Room-Temperature Stable Freeze-Dried Plasma on July 30, 2026
Posted in Medical Innovations FDA Approves First Ophthalmic Bevacizumab for Wet AMD: A Milestone Two Decades in the Making on July 25, 2026